ES2172072T3 - Derivados hidroxi y polihidroxi de cumarina, su preparacion y su accion antiviral. - Google Patents

Derivados hidroxi y polihidroxi de cumarina, su preparacion y su accion antiviral.

Info

Publication number
ES2172072T3
ES2172072T3 ES98118508T ES98118508T ES2172072T3 ES 2172072 T3 ES2172072 T3 ES 2172072T3 ES 98118508 T ES98118508 T ES 98118508T ES 98118508 T ES98118508 T ES 98118508T ES 2172072 T3 ES2172072 T3 ES 2172072T3
Authority
ES
Spain
Prior art keywords
derivatives
hydroxy
preparation
polyhydroxi
cumarina
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98118508T
Other languages
English (en)
Inventor
Mladen Prof Dr Trkovnik
Zrinka Ivezic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pliva Farmaceutika dd
Original Assignee
Pliva Farmaceutska Kemijska Prehrambena I Kozmeticka Industrija dd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Farmaceutska Kemijska Prehrambena I Kozmeticka Industrija dd filed Critical Pliva Farmaceutska Kemijska Prehrambena I Kozmeticka Industrija dd
Application granted granted Critical
Publication of ES2172072T3 publication Critical patent/ES2172072T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/42—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4
    • C07D311/44—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 with one hydrogen atom in position 3
    • C07D311/46—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 with one hydrogen atom in position 3 unsubstituted in the carbocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/42—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4
    • C07D311/44—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 with one hydrogen atom in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/42—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4
    • C07D311/44—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 with one hydrogen atom in position 3
    • C07D311/46—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 with one hydrogen atom in position 3 unsubstituted in the carbocyclic ring
    • C07D311/48—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 with one hydrogen atom in position 3 unsubstituted in the carbocyclic ring with two such benzopyran radicals linked together by a carbon chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/42—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4
    • C07D311/56—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 without hydrogen atoms in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A NUEVOS DERIVADOS HIDROXI Y POLIHIDROXI DE CUMARINA FUSIONADOS CON ACIDOS DIALDEHIDICOS Y ALDEHIDICOS DE LAS FORMULAS GENERALES I, II, III Y IV: EN LAS QUE R 1 = R 2 = 4 - HIDROXICUMARINA; R 1 = R 2 = 4,7 - DIHIDROXICUMARINA; R 1 = R 2 = 4,5,7 - TRIHIDROXICUMARINA; R 1 = 4 - HIDROXICUMARINA, R 2 = - CH(OH)CH 3 . LA INVENCION TAMBIEN SE REFIERE A PROCEDIMIENTOS PARA LA PREPARACION DE DERIVADOS HIDROXI Y POLIHIDROXI DE CUMARINA FUSIONADOS CON ACIDOS DIALDEHIDICOS Y ALDEHIDICOS Y A LA ACCION ANTIVIRICA DE LOS MISMOS. LOS NUEVOS DERIVADOS HIDROXI Y POLIHIDROXI DE CUMARINA DE LA PRESENTE INVENCION PRESENTAN UNA ACCION ANTIVIRICA CONTRA EL VIRUS VIH - 1.
ES98118508T 1997-10-02 1998-09-30 Derivados hidroxi y polihidroxi de cumarina, su preparacion y su accion antiviral. Expired - Lifetime ES2172072T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HR970529A HRP970529B1 (en) 1997-10-02 1997-10-02 Novel hydroxy and polyhydroxy derivatives of cumarin, preparation thereof and antiviral action thereof

Publications (1)

Publication Number Publication Date
ES2172072T3 true ES2172072T3 (es) 2002-09-16

Family

ID=10946634

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98118508T Expired - Lifetime ES2172072T3 (es) 1997-10-02 1998-09-30 Derivados hidroxi y polihidroxi de cumarina, su preparacion y su accion antiviral.

Country Status (22)

Country Link
US (2) US6100409A (es)
EP (1) EP0906909B1 (es)
JP (3) JP3139996B2 (es)
CN (1) CN1101814C (es)
AT (1) ATE212625T1 (es)
AU (1) AU747394B2 (es)
BG (1) BG63543B1 (es)
CA (1) CA2246052A1 (es)
CZ (1) CZ314398A3 (es)
DE (1) DE69803642T2 (es)
DK (1) DK0906909T3 (es)
ES (1) ES2172072T3 (es)
HR (1) HRP970529B1 (es)
HU (1) HUP9802178A3 (es)
NO (1) NO984590L (es)
NZ (1) NZ332147A (es)
PL (1) PL328935A1 (es)
PT (1) PT906909E (es)
RU (1) RU2207338C2 (es)
SI (1) SI0906909T1 (es)
SK (1) SK283173B6 (es)
UA (1) UA63903C2 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP970529B1 (en) * 1997-10-02 2003-06-30 Pliva Pharm & Chem Works Novel hydroxy and polyhydroxy derivatives of cumarin, preparation thereof and antiviral action thereof
FI20001593A7 (fi) * 2000-07-03 2002-01-04 Orion Yhtymo Oyj Comt-entsyymiõ inhiboivaa aktiivisuutta omaavia kumariinijohdannaisia
CN1282944C (zh) 2000-12-10 2006-11-01 Vkr控股公司 遥控装置及其配置方法
EP1448543A1 (en) * 2001-10-01 2004-08-25 PLIVA-ISTRAZIVACKI INSTITUT d.o.o. Products of condensations of hydroxycoumarin derivatives with aromatic and aliphatic dialdehydes, their preparation and antiviral action thereof
HRP20030604A2 (en) * 2003-07-25 2005-04-30 Pliva-Istra�iva�ki institut d.o.o. Substituted furochromenes, preparation thereof andtheir antiinflammatory action
HRP20030603A2 (en) 2003-07-25 2005-10-31 Pliva-Istra�iva�ki institut d.o.o. Substituted furochromene compounds of antiinflammatory action
DE102004032440B4 (de) * 2004-07-05 2007-02-08 Bioplanta Arzneimittel Gmbh Verwendung von trisubstituierten Benzopyranonen
DE102009029050A1 (de) * 2009-08-31 2011-03-03 Evonik Oxeno Gmbh Organophosphorverbindungen basierend auf Tetraphenol(TP)-substituierten Strukturen
JP6863067B2 (ja) * 2017-05-17 2021-04-21 Dic株式会社 δ−バレロラクトン骨格含有樹脂
CN111297851B (zh) * 2020-04-02 2021-03-23 中国农业科学院蜜蜂研究所 香豆素在蜜蜂抗病毒感染中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU950728A1 (ru) * 1981-01-23 1982-08-15 Пермский государственный фармацевтический институт Способ получени 6-арил-3-ароил-4-окси-5-бромпиран-2-онов
RU2036917C1 (ru) * 1989-11-28 1995-06-09 Санкио Компани Лимитед Производные кумарина или их фармацевтически приемлемая соль
HUT63843A (en) * 1992-02-13 1993-10-28 Biosignal Kutato Fejlesztoe Kf Process for producing new kumarin derivatives and their analogs inhibiting mammal cell proliferation and tumour growth, as well as pharmaceutical comkpositions comprising such compounds
US5672607A (en) * 1993-01-29 1997-09-30 The United States Of America As Represented By The Department Of Health And Human Services Antiviral naphthoquinone compounds, compositions and uses thereof
HRP970529B1 (en) * 1997-10-02 2003-06-30 Pliva Pharm & Chem Works Novel hydroxy and polyhydroxy derivatives of cumarin, preparation thereof and antiviral action thereof

Also Published As

Publication number Publication date
ATE212625T1 (de) 2002-02-15
SI0906909T1 (en) 2002-06-30
EP0906909A1 (en) 1999-04-07
NO984590D0 (no) 1998-10-01
CZ314398A3 (cs) 1999-05-12
SK136798A3 (en) 1999-05-07
HUP9802178A3 (en) 2002-05-28
PT906909E (pt) 2002-07-31
SK283173B6 (sk) 2003-03-04
CA2246052A1 (en) 1999-04-02
AU747394B2 (en) 2002-05-16
NO984590L (no) 1999-04-06
HRP970529A2 (en) 1999-06-30
HUP9802178A2 (hu) 2000-05-28
AU8788698A (en) 1999-04-22
BG102813A (en) 1999-07-30
US6291518B1 (en) 2001-09-18
JP3139996B2 (ja) 2001-03-05
RU2207338C2 (ru) 2003-06-27
PL328935A1 (en) 1999-04-12
NZ332147A (en) 1999-05-28
CN1101814C (zh) 2003-02-19
DE69803642D1 (de) 2002-03-14
CN1220263A (zh) 1999-06-23
HU9802178D0 (en) 1998-11-30
HRP970529B1 (en) 2003-06-30
DK0906909T3 (da) 2002-04-29
JP2001089467A (ja) 2001-04-03
UA63903C2 (uk) 2004-02-16
BG63543B1 (bg) 2002-04-30
DE69803642T2 (de) 2002-10-02
JPH11158169A (ja) 1999-06-15
EP0906909B1 (en) 2002-01-30
JP2001089466A (ja) 2001-04-03
US6100409A (en) 2000-08-08

Similar Documents

Publication Publication Date Title
BR0116470A (pt) éteres de imidazoquinolina substituìdos com uréia
ES2530769T3 (es) Métodos para la activación de células T in vivo por células dendríticas pulsadas con antígeno
ES2172072T3 (es) Derivados hidroxi y polihidroxi de cumarina, su preparacion y su accion antiviral.
HN2001000027A (es) Derivados de purina
MX9304581A (es) Desoxitaxoles y composiciones farmaceuticas que los contienen
CO5160274A1 (es) Composicion protectora de la piel y su aplicacion en articu los absorbentes
ES2107762T3 (es) Utilizacion de un alquilester de glutation en una composicion cosmetica o dermatologica destinada al tratamiento por via topica del envejecimiento cutaneo.
ES2091728B1 (es) Formulaciones de analogos de insulina monomericos.
ES2042737T3 (es) Un procedimiento para la preparacion de un glucosido de antraciclina.
MX9301053A (es) Guanidinas [(benzodioxan, benzofuran o benzopiran)-alquilamino]-alquil-substituidas.
ES2169147T3 (es) Derivados de beta-carbolina agonistas de la melatonina, sus procedimientos de preparacion y su utilizacion a titulo de medicamento.
MX9503529A (es) Derivados de glicinamida, procedimiento para su preparacion y medicamentos que los contienen.
ES2173487T3 (es) Nuevo derivado de genipina que tiene actividad contra el virus de hepatitis b.
ES2108969T3 (es) Utilizacion de analogos de didesoxinucleosidos en el tratamiento de infecciones virales.
ES2105285T3 (es) Nuevos derivados de la adenosina, sus procedimientos de preparacion, composiciones farmaceuticas que los contienen.
GT199900202A (es) Derivados de indol.
ES2159054T3 (es) Compuestos di-terc-butil-fenolicos que contienen azufre utiles como agentes antiinflamatorios.
HN1999000101A (es) Inhibidores de las fkbp.
ES2106623T3 (es) Nuevo procedimiento de preparacion de un esteroide 16betametilo y nuevos productos intermedios.
AR003093A1 (es) Nuevos derivados de imidazol-n-bencildioxol, su procedimiento de preparacion, su aplicacion a titulo de medicamentos, composicionesfarmaceuticas y nueva utilizacion.
AR026243A1 (es) Solucion oral de galantamina
HN2000000057A (es) Derivados de i - trifluorometil-4-hidroxi-7-piperidinil- aminometilcromano.
PE130099A1 (es) Nuevos derivados de la equinocandina, su procedimiento de preparacion y su aplicacion como fungicidas
ES2196645T3 (es) Composiciones transparentes para el cuidado de la piel.
HN2001000021A (es) Nuevos derivados de amidas heterociclicas

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 906909

Country of ref document: ES